Cordasco Financial Network acquired a new stake in Aethlon Medical, Inc. (NASDAQ:AEMD) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 203,957 shares of the medical equipment provider’s stock, valued at approximately $230,000. Cordasco Financial Network owned approximately 1.35% of Aethlon Medical at the end of the most recent quarter.
Several equities analysts recently issued reports on the company. ValuEngine cut Aethlon Medical from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 11th. HC Wainwright assumed coverage on Aethlon Medical in a research report on Monday, November 20th. They issued a “buy” rating and a $3.00 price objective on the stock.
Aethlon Medical, Inc. (NASDAQ AEMD) opened at $1.40 on Friday. The stock has a market capitalization of $20.38, a P/E ratio of -1.94 and a beta of 2.10. Aethlon Medical, Inc. has a 12-month low of $0.79 and a 12-month high of $5.17. The company has a debt-to-equity ratio of 78.00, a current ratio of 2.97 and a quick ratio of 2.97.
Aethlon Medical Company Profile
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Want to see what other hedge funds are holding AEMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aethlon Medical, Inc. (NASDAQ:AEMD).
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.